Fig. 1From: Ombitasvir/paritaprevir/ritonavir & dasabuvir ± ribavirin following protease inhibitors failure - a prospective multi-centre trialHepatitis C Viral load. Per-protocol scatter plot of entire cohort’s patient’s viral load according to study period. * One patient had a breakthrough after 12 weeks of treatment. Non-c, non-cirrhoticBack to article page